CHICAGO (Reuters) - A sudden spike in blood levels of prostate specific antigen, or PSA, is not an accurate way to predict prostate cancer, and testing for such changes can lead to overtreatment, U.S.
CHICAGO—PSA levels at the time of initial screening among men aged 44-50 years can accurately predict the risk that a man will die from prostate cancer (PCa) or develop metastatic PCa up to 30 years ...
A recent BBC investigation questioned the accuracy of prostate-specific antigen (PSA) self-tests – rapid at-home tests for men worried about prostate cancer. The BBC analysed five of these tests using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results